| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/17/2015 | US8956623 Recombinant fusion interferon for animals |
| 02/17/2015 | US8956622 Peptidic antagonists of class III semaphorins/neuropilins complexes |
| 02/17/2015 | US8956620 Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine |
| 02/17/2015 | US8956617 Vaccination by transcutaneous targeting |
| 02/17/2015 | US8956616 Constructs binding to phosphatidylserine and their use in disease treatment |
| 02/17/2015 | US8956612 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker |
| 02/17/2015 | US8956611 Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease |
| 02/17/2015 | US8956605 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
| 02/17/2015 | US8956600 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2015 | US8956590 Compositions and methods for reducing the incidence of equine digestive disorders |
| 02/17/2015 | CA2727317C Melanocortin receptor-specific peptides for treatment of sexual dysfunction |
| 02/17/2015 | CA2669524C Collagen peptide composition and food or beverage containing the same |
| 02/17/2015 | CA2662209C Implantable devices for producing insulin |
| 02/17/2015 | CA2649842C Composition containing peptide as active ingredient |
| 02/17/2015 | CA2586081C Use of a bacterial vector comprising a saccharide inducible promoter as an expression system |
| 02/17/2015 | CA2563103C Enhancer of anticancer activity in viral therapy and method of preventing or treating cancer |
| 02/17/2015 | CA2557151C Peptide analogues of gip for treatment of diabetes, insulin resistance and obesity |
| 02/17/2015 | CA2541006C Tim-3 polypeptides |
| 02/17/2015 | CA2511814C Polymer conjugates of interferon-beta with enhanced biological potency |
| 02/17/2015 | CA2506331C Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 02/17/2015 | CA2506129C 2'-branched nucleosides and flaviviridae mutation |
| 02/17/2015 | CA2494384C A segment of glycosylation-deficient hgf .alpha.-chain |
| 02/12/2015 | WO2015021444A1 Combination of ifn-gamma with anti-erbb antibody for the treatment of cancers |
| 02/12/2015 | WO2015021376A1 Immunoglobulin expression levels as biomarker for proteasome inhibitor response |
| 02/12/2015 | WO2015021358A2 Compounds and methods for inhibiting phosphate transport |
| 02/12/2015 | WO2015021187A1 Mutants of cocaine esterase |
| 02/12/2015 | WO2015020943A2 Digestive enzyme composition suitable for enteral administration |
| 02/12/2015 | WO2015020765A2 Unglycosylated lysostaphin variant protein |
| 02/12/2015 | WO2015020690A1 Coordinated coexpression of thrombin |
| 02/12/2015 | WO2015020499A1 Composition for improving skin conditions comprising a fragment of human heat shock protein 90a as an active ingredient |
| 02/12/2015 | WO2015020186A1 Tablet composition |
| 02/12/2015 | WO2015020122A1 Urothelial cancer diagnosis and therapeutic agent |
| 02/12/2015 | WO2015019376A1 Synthetic cyclic peptides, agonists and antagonists of urotensin-ii and process for the production thereof |
| 02/12/2015 | WO2015019318A1 Peptides capable of reactivating p53 mutants |
| 02/12/2015 | WO2015019311A1 Somatostatin receptor modulator for the treatment of infertility |
| 02/12/2015 | WO2015019297A1 The synthesis of core-shell metal-semiconductor nanomaterials |
| 02/12/2015 | WO2015019269A1 Labelled ligands of anti-mullerian hormone for the diagnosis of endometriosis |
| 02/12/2015 | WO2015019198A2 High potency pancreatin pharmaceutical compositions |
| 02/12/2015 | WO2015018840A2 Novel means to decrease the negative effects of smoking |
| 02/12/2015 | WO2015018827A1 Ndp-msh for treatment of inflammatory and/or neurodegenerative disorders of the cns |
| 02/12/2015 | WO2015018805A1 Novel immunotherapy against several tumors, such as lung cancer, including nsclc |
| 02/12/2015 | WO2015018472A1 Intraarticular application of pepstatin in the case of arthrosis |
| 02/12/2015 | WO2015018421A1 Antibodies, compounds and derivatives thereof for use in the treatment of male infertility |
| 02/12/2015 | WO2015018375A1 Depression regulatory factor and applications thereof |
| 02/12/2015 | WO2015017949A1 Novel use of fibroblast growth factor 2 |
| 02/12/2015 | WO2015017888A1 Contaminant removal method |
| 02/12/2015 | US20150047064 INHIBITING GENE EXPRESSION WITH dsRNA |
| 02/12/2015 | US20150047063 DELIVERY OF dsRNA TO ARTHROPODS |
| 02/12/2015 | US20150047059 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 02/12/2015 | US20150045719 Combination of a mc1r receptor agonist and uvb for the treatment and/or prevention of pigmentation disorders |
| 02/12/2015 | US20150045536 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 02/12/2015 | US20150045312 Use of Compounds Elevating Glutathione Levels for the Treatment of Autism, Autistic Spectrum Disorders and Fragile X Syndrome |
| 02/12/2015 | US20150045311 Alkylated cyclodextrin compositions and processes for preparing and using the same |
| 02/12/2015 | US20150045310 Novel engineered potent cytotoxic stapled bh3 peptides |
| 02/12/2015 | US20150045309 Cyclosporin emulsions |
| 02/12/2015 | US20150045307 Identification of a novel bhd gene |
| 02/12/2015 | US20150045306 Determination of single nucleotide polymorphisms useful to predict response for glatiramer acetate |
| 02/12/2015 | US20150045305 Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
| 02/12/2015 | US20150045303 Pharmaceutical Composition Suitable for Treatment of Haemophilia |
| 02/12/2015 | US20150045302 Peptides |
| 02/12/2015 | US20150045301 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
| 02/12/2015 | US20150045300 Fast dissolving pharmaceutical composition |
| 02/12/2015 | US20150045298 Composition including stem cell-derived microvesicles for promoting neurogenesis |
| 02/12/2015 | US20150045297 Growth differentiation factor (gdf) for treatment of diastolic heart failure |
| 02/12/2015 | US20150045296 Method for treating diabetic retinopathy |
| 02/12/2015 | US20150045295 Dry powder inhaler and system for drug delivery |
| 02/12/2015 | US20150045292 Methods and composition for inducing satiety |
| 02/12/2015 | US20150045289 Method of pre-preparing medications for therapeutic uses |
| 02/12/2015 | US20150045283 Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods |
| 02/12/2015 | US20150045281 Glp-1 prodrugs |
| 02/12/2015 | US20150044296 Combination therapy to improve joint, tendon, and ligament healing |
| 02/12/2015 | US20150044292 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/12/2015 | US20150044276 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/12/2015 | US20150044275 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/12/2015 | US20150044274 Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery |
| 02/12/2015 | US20150044273 Molluscum contagiosum viral fusion protein treatment for atopic dermatitis diseases |
| 02/12/2015 | US20150044260 Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles |
| 02/12/2015 | US20150044259 Scaffold for enhanced neural tissue regeneration |
| 02/12/2015 | US20150044247 Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses |
| 02/12/2015 | US20150044239 Compositions and Methods for Diagnosing, Preventing and Treating Intracranial Aneurysms |
| 02/12/2015 | US20150044230 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/2015 | US20150044229 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
| 02/12/2015 | US20150044228 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 02/12/2015 | US20150044207 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia |
| 02/12/2015 | US20150044193 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTION |
| 02/12/2015 | US20150044190 Product and process for liquefaction of mucus or sputum |
| 02/12/2015 | US20150044188 Antiviral methods and compositions comprising probiotic bacterial molecules |
| 02/12/2015 | US20150044173 Microbiota restoration therapy (mrt), compositions and methods of manufacture |
| 02/12/2015 | US20150044171 Gain-of-Function ADAMTS13 Variants Resistant to Auto Antibody Inhibition and Methods of Use Thereof |
| 02/12/2015 | US20150044169 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
| 02/12/2015 | US20150044165 Costimulatory b7-h1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target |
| 02/12/2015 | US20150044164 Methods of Treating Autoimmune Diseases |
| 02/12/2015 | US20150044163 A Method for Cuticle Growth using Granulocyte-Colony Stimulating Factor |
| 02/12/2015 | US20150044148 Method for Treating Capillary Hemangiomas |
| 02/12/2015 | US20150044145 Materials and methods for treatment of cystic fibrosis and for induction of ion secretion |
| 02/12/2015 | US20150044134 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
| 02/11/2015 | EP2835136A1 Somatostatin Receptor Modulator for the treatment of infertility |
| 02/11/2015 | EP2835135A2 Means and methods for treating pseudomonas infection |
| 02/11/2015 | EP2834268A1 Modified peptide toxins |
| 02/11/2015 | EP2834262A1 Methods of treatment with arginine deiminase |